TFAP4 inhibits differentiation of MYCN-amplified neuroblastoma

被引：0
|
作者：
Zhang, Shuobo [1 ]
Lopez, Gonzalo [1 ]
Yu, Jiyang [2 ]
Silva, Jose [3 ]
Kadenhe-Chiweshe, Angela [1 ]
Califano, Andrea [1 ]
Yamashiro, Darrell [1 ]
机构：
[1] Columbia Univ, New York, NY USA
[2] Pfizer, New York, NY USA
[3] Mt Sainai Med Sch, New York, NY USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-2083
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2083
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A MYCN-INDEPENDENT MECHANISM MEDIATING SECRETOME REPROGRAMMING AND METASTASIS IN MYCN-AMPLIFIED NEUROBLASTOMA
    Zhang, Hai-Feng
    Delaidelli, Alberto
    Javed, Sumreen
    Turgu, Busra
    Yang, Xiaqiu
    Lizardo, Michael
    Martinez, Daniel
    Maris, John
    Bosse, Kristopher
    Williams, Karla
    Sorensen, Poul
    PEDIATRIC BLOOD & CANCER, 2023, 70 : S67 - S68
  • [32] GENETIC VARIANTS IN KIF15 ARE ASSOCIATED WITH MYCN-AMPLIFIED NEUROBLASTOMA
    Applebaum, M. A.
    Hungate, E.
    Skol, A.
    Vaksman, Z.
    Diamond, M.
    McDaniel, L.
    Volchenboum, S.
    Stranger, B.
    Diskin, S.
    Maris, J.
    Onel, K.
    Cohn, S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S20 - S21
  • [33] The Impact of Chemo-Sensitivity on Surgical Resection in MYCN-Amplified Neuroblastoma
    Chui, C. H.
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S86 - S86
  • [34] Macrophage infiltration promotes regrowth in MYCN-amplified neuroblastoma after chemotherapy
    Valind, Anders
    Verhoeven, Bronte Manouk
    Enoksson, Jens
    Karlsson, Jenny
    Christensson, Gustav
    Manas, Adriana
    Aaltonen, Kristina
    Jansson, Caroline
    Bexell, Daniel
    Baryawno, Ninib
    Gisselsson, David
    Hagerling, Catharina
    ONCOIMMUNOLOGY, 2023, 12 (01):
  • [35] The super elongation complex drives transcriptional addiction in MYCN-amplified neuroblastoma
    Wang, Donghai
    Yin, Zhinang
    Wang, Honghong
    Wang, Liyuan
    Li, Tianyu
    Xiao, Ruijing
    Xie, Ting
    Han, Ruyi
    Dong, Rui
    Liu, Hudan
    Liang, Kaiwei
    Qing, Guoliang
    SCIENCE ADVANCES, 2023, 9 (13)
  • [36] GMDS is a key driver of MYCN-amplified neuroblastoma core fucosylation and tumorigenesis
    Zhu, Beibei
    Pitts, Michelle
    Buoncristiani, Michael
    Bryant, Lindsay
    Lopez-Nunez, Oscar
    Gurria, Juan
    Shedlock, Cameron
    Ribas, Roberto
    Keohane, Shannon
    Liu, Jinpeng
    Wang, Chi
    Gentry, Matt
    Shelman, Nathan
    Allison, Derek
    Evers, B. Mark
    Sun, Ramon
    Rellinger, Eric J.
    CANCER RESEARCH, 2024, 84 (06)
  • [37] Induction of MYCN-amplified neuroblastoma differentiation through NMYC suppression using PPAR-y antagonist
    Nakao-Ise, Yukako
    Narita, Takumi
    Miyamoto, Shingo
    Watanabe, Motoki
    Tanaka, Takuji
    Sowa, Yoshihiro
    Iizumi, Yosuke
    Masuda, Mitsuharu
    Fujii, Gen
    Hirai, Yasuko
    Nakao, Toshimasa
    Takakura, Hideki
    Mutoh, Michihiro
    JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION, 2023, 73 (03) : 191 - 197
  • [38] The genetic tumor background is an important determinant for heterogeneous MYCN-amplified neuroblastoma
    Bogen, Dominik
    Brunner, Clemens
    Walder, Diana
    Ziegler, Andrea
    Abbasi, Reza
    Ladenstein, Ruth L.
    Noguera, Rosa
    Martinsson, Tommy
    Amann, Gabriele
    Schilling, Freimut H.
    Ussowicz, Marek
    Benesch, Martin
    Ambros, Peter F.
    Ambros, Inge M.
    INTERNATIONAL JOURNAL OF CANCER, 2016, 139 (01) : 153 - 163
  • [39] Dual BRD4 and AURKA Inhibition Is Synergistic against MYCN-Amplified and Nonamplified Neuroblastoma
    Felgenhauer, Joshua
    Tomino, Laura
    Selich-Anderson, Julia
    Bopp, Emily
    Shah, Nilay
    NEOPLASIA, 2018, 20 (10): : 965 - 974
  • [40] CD55, a potential immunotherapeutic target for MYCN-amplified neuroblastoma
    Yoda, Hiroyuki
    Weiss, William A.
    NEURO-ONCOLOGY, 2022, 24 (06) : 886 - 887
12345